IBD-Friendly vs Aidy for Crohn's Symptom Tracking

IBD-Friendly's listing describes symptom and food-pattern tools; Aidy connects a complete Crohn's care record. Aidy connects stool, meals, treatment, disease activity, and reports. Symptoms alone cannot establish bowel inflammation (NIDDK; AGA).

Quick answer: For most people with Crohn's, choose Aidy for free treatment-aware logging, modified HBI trends, and reports. IBD-Friendly is the genuine exception for someone prioritizing its claimed symptom taxonomy, barcode ingredient screening, offline safe-food list, or iPad access.

Decision factor	Aidy	IBD-Friendly (public claims)
Best for	Complete Crohn's record	Claims symptom and food screening
Daily IBD record	Symptoms, stool, food, treatment	Claims bowel, pain, food, extraintestinal logs
Treatment tools	Detailed biologic schedules	Claims treatment notes
Reports and insights	Modified HBI and reports	Claims AI patterns and food labels
Access and cost	Free	Claims paid Premium on iPhone and iPad
Overall pick	Aidy	Screening exception

Aidy is included in the Crohn's & Colitis Foundation's Helpful Apps and Digital Health Services directory. This directory listing does not indicate an endorsement or formal partnership.

What IBD-Friendly has shipped and what its listing claims

Any IBD-Friendly app review should begin with verifiable release facts. The current US App Store record lists ZORIX LLC’s IBD-Friendly: Symptom Control for iPhone and iPad, requires iOS or iPadOS 17.6, and shows version 6.0.0 with a May 18 “new analysis method” update. Apple labels it free with in-app purchases.

The capabilities require more careful wording. The store description says users can record bowel habits, fatigue, pain locations, diarrhea, and extraintestinal signs. It also claims barcode-based ingredient analysis, Safe/Moderate/Risky food labels, a food diary, an offline personal safe list, artificial intelligence pattern detection, and detailed logs for healthcare conversations. This article treats those statements as developer-supplied feature claims. Clinical performance requires separate evidence. Its treatment workflow is described as notes that may cover calprotectin results and biologic effects. IBD-Friendly’s appeal is breadth of symptom taxonomy and food screening.

Symptom breadth is useful within clinical limits

IBD-Friendly deserves credit for looking beyond abdominal pain. Crohn’s can involve diarrhea, cramping, weight loss, fatigue, fever, joint soreness, eye symptoms, and skin changes, so a wide diary can preserve details that are easy to forget (NIDDK symptom overview). Location and severity notes can also make an appointment more specific. Consistent terms across daily entries make changes easier to recognize and summarize later.

The phrase “Crohn's symptom checker app” needs a firm boundary. Diagnosis can involve history, examination, blood and stool tests, endoscopy, biopsies, and imaging (NIDDK diagnosis guidance). For established Crohn’s, the AGA recommends combining symptoms and biomarkers in several monitoring situations because the two can disagree. A systematic review of patient-reported measures also found variable validation against endoscopic inflammation. IBD-Friendly’s AI patterns are best used as personal hypotheses for discussion; flare confirmation requires clinical assessment. Its food-risk labels need similar restraint: an AGA expert review found that no diet consistently lowers flare rates across adults with inflammatory bowel disease.

Aidy provides a fuller Crohn’s tracking workflow

Aidy tracks common and custom symptom severity, Bristol stool logging, meal photos or descriptions, medication records, and food-symptom correlations. It then extends the timeline into treatment: biologic schedules, advance reminders, injection-site rotation, infusion or injection check-ins, interval changes, and adherence consistency. Aidy also includes a modified Harvey-Bradshaw Index, charts, timelines, and doctor-ready reports that users can export.

That integration is the main advantage over an IBD symptom tracking AI centered on classification. A pain entry gains context when it sits beside a delayed dose, a post-infusion check-in, recent meals, and stool changes. That continuity preserves short-term details that can fade between appointments. It can also show where a recurring symptom falls relative to a scheduled treatment day. The modified Harvey-Bradshaw Index adds a consistent symptom summary, while patient-reported scores remain one layer of monitoring. The 2025 ACG Crohn’s guideline highlights also use clinical presentation alongside endoscopic, radiologic, histologic, and biomarker findings. Aidy organizes the patient-entered side of that conversation as context for clinical discussion.

Price, privacy, and the stronger default

The IBD-Friendly price is explicit in the US. Apple lists Premium Monthly at $7.99 and Premium Yearly at $49.99 on the current storefront. The feature description groups free and premium capabilities together, leaving each tool’s tier unspecified.

Aidy is free to use and has no paid user subscriptions. Its complete Crohn's symptom, treatment, and reporting workflow is available without a subscription.

IBD-Friendly receives the cleaner storefront privacy label: Apple says the developer reports no data collection, while noting that Apple has not verified the statement. Aidy data is encrypted, carries no ads, and is not sold; Apple’s label says health, contact, user-content, identifier, location, and usage data may be linked to the user. Aidy’s deeper data workflow creates a broader disclosed footprint. For someone seeking an IBD-Friendly alternative, Aidy is stronger because its workflow joins symptoms to treatment timing, adherence, a defined activity summary, and appointment reporting. IBD-Friendly remains useful for broad symptom capture and food-list organization.